Recombinant Human monoclonal antibody expressed in CHO binding to HIV gp41. The anti-HIV-1 gp41 antibodiess are used for a therapeutic treatment against HIV infection by reducing viral load levels within an infected individual, thus prolonging the asymptomatic phase of HIV infection.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-471 | Recombinant Anti-HIV gp41 Antibody | ELISA, IP, FuncS | IgG |
MHH-471 | Recombinant Human Anti-HIV gp41 Antibody | RIA, WB, FuncS | IgG |
FAMAB-0082WJ | Human Anti-HIV gp41 Recombinant Antibody (clone NO.86) | ELISA, WB | Human IgG1, κ |
FAMAB-0099WJ | Human Anti-HIV gp41 Recombinant Antibody (clone 120-16) | ELISA | Human IgG2 |
FAMAB-0262JF | Monkey Anti-HIV gp41 Recombinant Antibody (clone B402) | WB, ELISA, IHC, FC | Monkey IgG |
There are currently no Customer reviews or questions for TAB-356CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.